Tag: Long acting beta agonist

Cardiovascular disease is a significant comorbidity in approximately 38% of patients with Chronic Obstructive Pulmonary Disease (COPD). As a result, the question, 'Is indacaterol cardiac safety a concern?', is critically important for both patients and clinicians when considering long-term treatment for respiratory conditions.

According to Health Canada, Zenhale, which contains the active ingredients mometasone and formoterol, is approved as a maintenance treatment for asthma. The answer to the question, **what kind of inhaler is Zenhale?** is that it is a combination inhaler used for long-term control, not for immediate relief of symptoms.